Collegium Pharmaceutical, Inc
COLLFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Collegium Pharmaceutical, Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 13 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 10, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Horizon Investments, LLC | 2026-03-31 | 18,980 | $628K | SEC filing |
| EMERALD ADVISERS, LLC | 2026-03-31 | 402,752 | $13.3M | SEC filing |
| Keating Financial Advisory Services, Inc. | 2026-03-31 | 25 | $827 | SEC filing |
| Aquatic Capital Management LLC | 2026-03-31 | 15,181 | $502K | SEC filing |
| Creative Planning | 2026-03-31 | 29,638 | $980K | SEC filing |
| Empowered Funds, LLC | 2026-03-31 | 57,384 | $1.9M | SEC filing |
| CITADEL ADVISORS LLC | 2026-03-31 | 121,366 | $4.01M | SEC filing |
| Engineers Gate Manager LP | 2026-03-31 | 49,814 | $1.65M | SEC filing |
| ENVESTNET ASSET MANAGEMENT INC | 2026-03-31 | 61,048 | $2.02M | SEC filing |
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 360,826 | $11.9M | SEC filing |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-03-31 | 29,443 | $974K | SEC filing |
| BROWN BROTHERS HARRIMAN & CO | 2026-03-31 | 243 | $8.04K | SEC filing |
| Round Rock Advisors LLC | 2026-03-31 | 10,690 | $354K | SEC filing |
| Private Wealth Asset Management, LLC | 2026-03-31 | 289 | $9.56K | SEC filing |
| EVOLVE PRIVATE WEALTH, LLC | 2026-03-31 | 23,520 | $778K | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 10,076 | $333K | SEC filing |
| Balyasny Asset Management L.P. | 2026-03-31 | 27,039 | $894K | SEC filing |
| SummerHaven Investment Management, LLC | 2026-03-31 | 22,756 | $753K | SEC filing |
| MetLife Investment Management, LLC | 2026-03-31 | 18,326 | $606K | SEC filing |
- Each value is checked against Collegium Pharmaceutical, Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- 1 row left out: the value per share it reports is far from Collegium Pharmaceutical, Inc's share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so it may describe another security or share class.
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-18 | Freund John Gordon · Director | Common Stock | S — Open market or private sale | −20 | 34.05 | SEC filing |
| 2026-05-15 | Freund John Gordon · Director | Common Stock | S — Open market or private sale | −4,127 | 34.54 | SEC filing |
| 2026-05-13 | Lurker Nancy · Director | Common Stock | S — Open market or private sale | −4,500 | 35.97 | SEC filing |
| 2026-05-11 | BOHLIN GAREN G · Director | Common Stock | S — Open market or private sale | −8,700 | 37.18 | SEC filing |
| 2026-03-18 | Dieter David · EVP & General Counsel | Common Stock | S — Open market or private sale | −13,976 | 34.92 | SEC filing |
| 2026-03-09 | Dieter David · EVP & General Counsel | Common Stock | S — Open market or private sale | −6,224 | 36.65 | SEC filing |
| 2026-03-03 | Dreyer Scott · EVP & Chief Commercial Officer | Common Stock | S — Open market or private sale | −46,417 | 40.36 | SEC filing |
| 2026-03-03 | Dreyer Scott · EVP & Chief Commercial Officer | Common Stock | S — Open market or private sale | −3,559 | 40.99 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-08 | SANTINI GINO · Director | Stock Option (Right to Purchase) | M — Exercise or conversion of derivative security | −8,700 | SEC filing |
| 2026-06-08 | SANTINI GINO · Director | Common Stock | M — Exercise or conversion of derivative security | +8,700 | SEC filing |
| 2026-05-15 | Freund John Gordon · Director | Stock Option (Right to Purchase) | M — Exercise or conversion of derivative security | −8,700 | SEC filing |
| 2026-05-15 | Freund John Gordon · Director | Common Stock | M — Exercise or conversion of derivative security | +8,700 | SEC filing |
| 2026-05-14 | Glancy Donovan Michael · Director | Common Stock | A — Grant, award, or other acquisition | +17,482 | SEC filing |
| 2026-05-14 | Lurker Nancy · Director | Common Stock | A — Grant, award, or other acquisition | +8,741 | SEC filing |
| 2026-05-14 | SANTINI GINO · Director | Common Stock | A — Grant, award, or other acquisition | +8,741 | SEC filing |
| 2026-05-14 | Freund John Gordon · Director | Common Stock | A — Grant, award, or other acquisition | +8,741 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.